Literature DB >> 7786582

Coamplification of HIV type 1 and beta-globin gene DNA sequences in a nonisotopic polymerase chain reaction assay to control for amplification efficiency.

F Coutlée1, Y He, P Saint-Antoine, C Olivier, A Kessous.   

Abstract

The polymerase chain reaction (PCR) fails to detect HIV-1 sequences in 5% of infected individuals. To screen for false-negative PCR tests, we developed a nonisotopic PCR assay in which sequences from the beta-globin gene and from the HIV-1 vpu-env region were coamplified with biotinylated and fluorescein-labeled primers, respectively. Coamplified products were reacted with specific internal digoxigenin-labeled RNA probes. Hybrids were detected in a microtiter plate coated with streptavidin or anti-fluorescein antibody, with enzyme-labeled anti-digoxigenin antibody. After the optimization of the coamplification conditions, the assay could detect 5 proviral DNA copies in a lysate from 100,000 peripheral blood mononuclear cells. Fifty-seven samples from 55 HIV-1-seropositive patients and 25 samples from 25 seronegative individuals were evaluated. Fifty-two samples from HIV-infected individuals were positive for HIV-1 vpu-env sequences. Three of the 5 PBMC lysates falsely negative for HIV-1 sequences had reactivities for beta-globin (3-23 fu) below that of 100,000 cells (304 fu). Nonisotopic coamplification allowed for the evaluation of the quality of specimens for PCR concurrently with the detection of the presence of viral template sequences.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7786582     DOI: 10.1089/aid.1995.11.363

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  7 in total

1.  Low concentrations of HIV-1 DNA at birth delays diagnosis, complicating identification of infants for antiretroviral therapy to potentially prevent the establishment of viral reservoirs.

Authors:  Caroline Mitchell; Sandra Dross; Ingrid A Beck; Mark A Micek; Lisa M Frenkel
Journal:  Clin Infect Dis       Date:  2014-02-05       Impact factor: 9.079

2.  Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women.

Authors:  Caroline Mitchell; Jennifer E Balkus; David Fredricks; Congzhou Liu; Jennifer McKernan-Mullin; Lisa M Frenkel; Christina Mwachari; Amneris Luque; Susan E Cohn; Craig R Cohen; Robert Coombs; Jane Hitti
Journal:  AIDS Res Hum Retroviruses       Date:  2012-11-05       Impact factor: 2.205

3.  Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field.

Authors:  I A Beck; K D Drennan; A J Melvin; K M Mohan; A M Herz; J Alarcón; J Piscoya; C Velázquez; L M Frenkel
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

4.  Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan women.

Authors:  Caroline Mitchell; Jennifer E Balkus; Jennifer McKernan-Mullin; Susan E Cohn; Amneris E Luque; Christina Mwachari; Craig R Cohen; Robert Coombs; Lisa M Frenkel; Jane Hitti
Journal:  J Acquir Immune Defic Syndr       Date:  2013-02-01       Impact factor: 3.731

Review 5.  Comparison of competitive and positive control-based PCR quantitative procedures coupled with end point detection.

Authors:  F Mallet
Journal:  Mol Biotechnol       Date:  2000-03       Impact factor: 2.695

6.  Quantitation of human immunodeficiency virus type 1 DNA by two PCR procedures coupled with enzyme-linked oligosorbent assay.

Authors:  F Mallet; C Hebrard; J M Livrozet; O Lees; F Tron; J L Touraine; B Mandrand
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

7.  Persistence of human immunodeficiency virus type 1 subtype B DNA in dried-blood samples on FTA filter paper.

Authors:  Chung-Chen Li; Ingrid A Beck; Kristy D Seidel; Lisa M Frenkel
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.